eFFECTOR Therapeutics, Inc. (EFTR)

USD 0.0

(0.0%)

Long Term Debt Summary of eFFECTOR Therapeutics, Inc.

  • eFFECTOR Therapeutics, Inc.'s latest annual long term debt in 2023 was - USD , down -100.0% from previous year.
  • eFFECTOR Therapeutics, Inc.'s latest quarterly long term debt in 2024 Q1 was 179 Thousand USD , down 0.0% from previous quarter.
  • eFFECTOR Therapeutics, Inc. reported annual long term debt of 60 Thousand USD in 2022, down -99.7% from previous year.
  • eFFECTOR Therapeutics, Inc. reported annual long term debt of 19.98 Million USD in 2021, up 187.73% from previous year.
  • eFFECTOR Therapeutics, Inc. reported quarterly long term debt of 6000.00 USD for 2023 Q3, down -76.0% from previous quarter.
  • eFFECTOR Therapeutics, Inc. reported quarterly long term debt of 43 Thousand USD for 2023 Q1, down -28.33% from previous quarter.

Annual Long Term Debt Chart of eFFECTOR Therapeutics, Inc. (2023 - 2019)

Historical Annual Long Term Debt of eFFECTOR Therapeutics, Inc. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 - USD -100.0%
2022 60 Thousand USD -99.7%
2021 19.98 Million USD 187.73%
2020 6.94 Million USD 0.0%
2019 - USD 0.0%

Peer Long Term Debt Comparison of eFFECTOR Therapeutics, Inc.

Name Long Term Debt Long Term Debt Difference
America Great Health 1.12 Million USD 100.0%
Ampio Pharmaceuticals, Inc. - USD NaN%
Aridis Pharmaceuticals, Inc. 1.29 Million USD 100.0%
Biora Therapeutics, Inc. 43.73 Million USD 100.0%
Bio-Path Holdings, Inc. 10 Thousand USD 100.0%
Better Therapeutics, Inc. 10.34 Million USD 100.0%
Calithera Biosciences, Inc. 136 Thousand USD 100.0%
Comera Life Sciences Holdings, Inc. 120.3 Thousand USD 100.0%
Gene Biotherapeutics, Inc. - USD NaN%
Eloxx Pharmaceuticals, Inc. 8.69 Million USD 100.0%
Evelo Biosciences, Inc. 48.87 Million USD 100.0%
Evolutionary Genomics, Inc. 3.74 Million USD 100.0%
Finch Therapeutics Group, Inc. 28.4 Million USD 100.0%
Galera Therapeutics, Inc. 151.04 Million USD 100.0%
Innovation1 Biotech Inc. 218.99 Thousand USD 100.0%
Kiromic BioPharma, Inc. 911.5 Thousand USD 100.0%
Molecular Templates, Inc. 9.74 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD 100.0%
NexImmune, Inc. - USD NaN%
Orgenesis Inc. 19.06 Million USD 100.0%
Panbela Therapeutics, Inc. 4.19 Million USD 100.0%
Point of Care Nano-Technology, Inc. - USD NaN%
PaxMedica, Inc. Common Stock - USD NaN%
Scopus BioPharma Inc. - USD NaN%
Sorrento Therapeutics, Inc. 104.33 Million USD 100.0%
Statera Biopharma, Inc. 11.43 Million USD 100.0%
TRACON Pharmaceuticals, Inc. 732 Thousand USD 100.0%
Trevena, Inc. 35.23 Million USD 100.0%
Vaxxinity, Inc. 13.26 Million USD 100.0%
Vaccinex, Inc. 26 Thousand USD 100.0%
Vicapsys Life Sciences, Inc. - USD NaN%
Viracta Therapeutics, Inc. - USD NaN%
ZIVO Bioscience, Inc. - USD NaN%